MedKoo Cat#: 564448 | Name: F81-1144b

Description:

WARNING: This product is for research use only, not for human or veterinary use.

F81-1144b is a matrix metalloproteinase inhibitor which reduces secretion of very low density lipoprotein-triacylglycerol, thereby lowering TAG levels in serum and the liver. F81-1144b also lowers VLDL-TAG secretion, de novo FA synthesis in the liver, and serum levels of insulin and glucose.

Chemical Structure

F81-1144b
F81-1144b
CAS#306733-22-2 (free base)

Theoretical Analysis

MedKoo Cat#: 564448

Name: F81-1144b

CAS#: 306733-22-2 (free base)

Chemical Formula: C27H37N3O5

Exact Mass: 483.2733

Molecular Weight: 483.61

Elemental Analysis: C, 67.06; H, 7.71; N, 8.69; O, 16.54

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
306733-22-2 (free base) 328081-16-9 (HCl)
Synonym
F811144b; F81 1144b; F81-1144b
IUPAC/Chemical Name
(S)-3-(4-(Aminomethyl)phenyl)-2-((2R,3S)-3-(hydroxycarbamoyl)-2-isobutyl-6-phenylhexanamido)propanoic acid
InChi Key
GFAZZKCPOBPJMA-VXNXHJTFSA-N
InChi Code
InChI=1S/C27H37N3O5/c1-18(2)15-23(22(26(32)30-35)10-6-9-19-7-4-3-5-8-19)25(31)29-24(27(33)34)16-20-11-13-21(17-28)14-12-20/h3-5,7-8,11-14,18,22-24,35H,6,9-10,15-17,28H2,1-2H3,(H,29,31)(H,30,32)(H,33,34)/t22-,23+,24-/m0/s1
SMILES Code
O=C(O)[C@@H](NC([C@H](CC(C)C)[C@@H](C(NO)=O)CCCC1=CC=CC=C1)=O)CC2=CC=C(CN)C=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 483.61 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Kawashima Y, Eguchi Y, Yamazaki T, Karahashi M, Kawai H, Kudo N. Reduction in Secretion of Very Low Density Lipoprotein-Triacylglycerol by a Matrix Metalloproteinase Inhibitor in a Rat Model of Diet-Induced Hypertriglyceridemia. J Pharmacol Exp Ther. 2018 Jul;366(1):194-204. doi: 10.1124/jpet.117.246165. Epub 2018 May 7. PubMed PMID: 29735610.